R1 RCM Inc (RCM)
14.30
0.00 (0.00%)
USD |
NASDAQ |
Nov 15, 16:00
14.30
0.00 (0.00%)
After-Hours: 20:00
R1 RCM Revenue (Annual): 2.254B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.254B |
| December 31, 2022 | 1.806B |
| December 31, 2021 | 1.475B |
| December 31, 2020 | 1.270B |
| December 31, 2019 | 1.186B |
| December 31, 2018 | 868.50M |
| December 31, 2017 | 449.80M |
| December 31, 2016 | 592.60M |
| December 31, 2015 | 117.20M |
| Date | Value |
|---|---|
| December 31, 2014 | 210.14M |
| December 31, 2013 | 504.77M |
| December 31, 2012 | 72.25M |
| December 31, 2011 | 101.97M |
| December 31, 2010 | 606.29M |
| December 31, 2009 | 510.19M |
| December 31, 2008 | 398.47M |
| December 31, 2007 | 240.72M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.186B
Minimum
2019
2.254B
Maximum
2023
1.598B
Average
1.475B
Median
2021
Revenue (Annual) Benchmarks
| Panamera Holdings Corp | 0.10M |
| TruBridge Inc | 339.44M |
| PetMed Express Inc | 281.06M |
| LENZ Therapeutics Inc | 15.00M |
| Oruka Therapeutics Inc | -- |